
Oncternal Therapeutics ONCT
Quartalsbericht 2024-Q3
hinzugefügt 06.11.2024
Oncternal Therapeutics DPO 2011-2026 | ONCT
DPO Jährlich Oncternal Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 422 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 422 | 422 | 422 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Anika Therapeutics
ANIK
|
54.4 | $ 14.93 | 0.88 % | $ 219 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.93 | 0.51 % | $ 5.07 M | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.14 | 0.36 % | $ 443 M | ||
|
Ardelyx
ARDX
|
163 | $ 6.06 | 1.94 % | $ 1.46 B | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 23.93 | 1.27 % | $ 3.04 B | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Atossa Therapeutics
ATOS
|
2.25 K | $ 5.19 | -3.36 % | $ 44.7 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Aurinia Pharmaceuticals
AUPH
|
47.5 | $ 16.05 | 2.79 % | $ 2.16 B | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.41 | -0.35 % | $ 375 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Axon Enterprise
AXON
|
29.9 | $ 411.97 | -0.2 % | $ 31.2 B | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.65 | -1.12 % | $ 16.6 M | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
BioCardia
BCDA
|
68.1 K | $ 1.18 | -1.67 % | $ 7.87 M | ||
|
BioCryst Pharmaceuticals
BCRX
|
484 | $ 9.59 | 6.26 % | $ 1.98 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 9.46 | -3.47 % | $ 612 M | ||
|
BioMarin Pharmaceutical
BMRN
|
245 | $ 56.04 | 0.96 % | $ 10.7 B | ||
|
BioXcel Therapeutics
BTAI
|
34.2 K | $ 1.18 | -0.42 % | $ 14.4 M |